Establishment Labs delivered a robust third quarter in 2025, with worldwide revenue reaching $53.8 million, a 33.8% increase year-over-year. The company achieved a significant milestone by reporting positive Adjusted EBITDA of $1.2 million, ahead of the fourth quarter, and improved its gross margin to 70.1%. Net loss also narrowed to $11.1 million from $16.7 million in the prior year.
Worldwide revenue for Q3 2025 was $53.8 million, marking a 33.8% increase compared to the same period in 2024.
The company achieved positive Adjusted EBITDA of $1.2 million in Q3 2025, a substantial improvement from a $7.0 million loss in the prior year.
Gross margin improved to 70.1% in Q3 2025, up from 63.9% in the year-ago period, driven by geographic mix and higher average selling prices.
Net loss for the quarter significantly narrowed to $11.1 million from $16.7 million in Q3 2024.
Establishment Labs expects to exceed its previous 2025 revenue guidance, anticipating revenue to be over $210 million. The company is focused on achieving cash flow positive next year and expects to significantly surpass its US Motiva sales guidance.
Analyze how earnings announcements historically affect stock price performance